博士眼镜(300622) - 2025 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2025 was CNY 326,159,936.89, representing a 10.22% increase compared to CNY 295,927,317.03 in the same period last year[5] - Net profit attributable to shareholders increased by 20.54% to CNY 30,177,843.86 from CNY 25,035,454.54 year-on-year[5] - Basic and diluted earnings per share rose by 21.43% to CNY 0.17 from CNY 0.14 in the same quarter last year[5] - Total operating revenue for the current period reached ¥326,159,936.89, an increase of 10.4% from ¥295,927,317.03 in the previous period[22] - Net profit for the current period was ¥31,123,887.79, representing a growth of 23.6% compared to ¥25,150,314.24 from the previous period[23] - The total comprehensive income for the period was CNY 30,888,372.78, compared to CNY 26,433,125.01 in the previous period, representing an increase of approximately 16.5%[24] Cash Flow - The net cash flow from operating activities surged by 62.17% to CNY 96,035,273.73, up from CNY 59,219,362.15 in the previous year[5] - Cash inflow from investment activities reached CNY 314,209,354.11, significantly higher than CNY 24,885,623.60 in the previous period[27] - The net cash flow from investment activities was CNY 51,602,713.66, recovering from a negative CNY 47,005,966.03 in the previous period[27] - The net cash flow from financing activities was negative at CNY -94,314,583.66, worsening from CNY -32,383,573.51 in the previous period[27] - The company reported a decrease in other operating cash receipts to CNY 4,353,811.83 from CNY 7,507,011.71, a decline of approximately 42.8%[27] Assets and Liabilities - Total assets at the end of Q1 2025 were CNY 1,273,056,169.23, a 1.57% increase from CNY 1,253,370,901.92 at the end of the previous year[5] - Current assets totaled ¥947,047,758.16, a rise of 5.7% from ¥896,015,215.32 in the previous period[21] - The company's total liabilities decreased to ¥470,830,852.90 from ¥482,147,643.08, a reduction of 2.6%[21] - The equity attributable to shareholders increased to ¥790,611,260.49, up from ¥760,633,819.81, marking a growth of 3.9%[21] Inventory and Accounts Payable - Inventory increased by 32.30% to CNY 246,698,359.90, primarily due to increased stockpiling[9] - Accounts payable rose by 109.01% to CNY 92,116,657.46, driven by increased inventory purchases[9] - The company reported a significant increase in accounts receivable, which rose to ¥91,577,147.43 from ¥75,979,279.51, an increase of 20.5%[20] - Inventory levels increased to ¥246,698,359.90, compared to ¥186,463,335.97, reflecting a growth of 32.3%[20] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 49,291[12] - The total number of shares held by the top 10 unrestricted shareholders includes LOUISA FAN with 9,605,234 shares and ALEXANDER LIU with 8,872,916 shares[13] - The total number of restricted shares at the beginning of the period was 56,548,114, with 251,946 shares released during the period, resulting in an ending balance of 56,302,918 restricted shares[15] - The company has a total of 80,700 restricted shares held by other shareholders under the equity incentive plan[15] - The top 10 unrestricted shareholders do not have any known relationships or concerted actions beyond those disclosed[13] Investment and Financial Strategy - The company plans to issue convertible bonds to unspecified investors, with the proposal being accepted by the Shenzhen Stock Exchange[16] - The company’s board meetings and shareholder meetings have approved various proposals related to the issuance of convertible bonds[16] - The company is actively pursuing market expansion strategies through financial instruments like convertible bonds[16] Financial Position - The company's financial position shows a significant increase in liquid assets, which may enhance its investment capacity[18] - The cash and cash equivalents increased from 199,335,621.73 to 253,569,102.43, reflecting a growth of approximately 27.2%[18] - The trading financial assets rose from 128,146,988.11 to 146,115,174.02, indicating an increase of about 14%[18] - The company's cash and cash equivalents decreased to ¥145,793,988.57 from ¥210,079,625.21, a decline of 30.6%[20] - The total cash and cash equivalents at the end of the period amounted to CNY 251,077,388.74, compared to CNY 172,174,409.79 at the end of the previous period, marking an increase of about 45.8%[27]